PPARG and breast cancer: In this study, we observed that CUR pre-treatment for 5 days in CIS treated rats increased the PPAR-γ expression in mammary tumors and hence highest anticancer activity amongst the entire study drug-treated groups and this may be possibly responsible for the decreased proliferation and enhanced apoptosis of mammary cancer cells.